1. The study design is not appropriate to answer the research question "evaluate the effectiveness of treatments" because there isn't a control group.
2. There is insufficient detail in the methods. a)For example, it is not clear how many follow up questionnaires were sent out and when. Were they sent out at regular intervals on several occasions or just once? b) How many patients were approached? How many agreed to take part? Without this information, it is hard to know whether the patients recruited are representative of the population of patients attending the clinic. c) There is a high drop out rate. When did the drop outs happen? Immediately or at follow up? d) Page 11, line 33. The authors excluded cases with missing data. Was this missing data at assessment? Which groups were these patients allocated to? Did they have data at outcome? The authors should consider including the data and reporting N at assessment. 3. In the discussion, the authors need to be clearer about the limitations of this study. For example, drop out was not equal across all groups. In the psychology group the drop out was highest with retention rates varying from 33% (14/42), 61% (27/44), 40% (31/52). However this is not discussed.
4. The authors need to take care over some of their conclusions. For example page 16, line 8: "Considering that the options available on the National Health Service, mainly CBT and GET, are often perceived as coping strategies at best, and physically damaging at worst" may be considered inflammatory by many of your readers. In addition, the statements such as " tailored treatments such as described here may be more palatable, and hence effective." (page 16) go beyond the evidence presented in this paper.
VERSION 1 -AUTHOR RESPONSE
Reviewer: Dr Jonathan Price Clinical Tutor in Psychiatry University of Oxford I have no conflicts of interest to declare I enjoyed reading this manuscript, which is generally very well presented and easy to read and understand.
-study design. The research question is 'to evaluate whether treatments X/Y/Z reduce CFS-ME symptoms over a period of three months, and whether there are differences in treatment effectiveness between X, Y and Z'. The correct study design for this question is the RCT. The authors mention the preliminary nature of this study but, in my view, they fall into the trap of assigning causality to changes in symptoms which are unjustified with this level of evidence. There are several important limitations which very significantly limit the ability to assign causality -non-randomised design; high drop out rate (about 50%); and differential drop-out rate between groups (from 67% in the psychology group to 40% in the nutrition and combined groups). Response: The limitations have been discussed in more depth to avoid falling into the causality trap and highlighted by Dr Price and the differential drop-out rates have been discussed as per Dr Crawley"s point below. -methods. These ARE adequately described, apart from the description of the nature of the interventions. I am reasonably clear about the focus of each intervention, and some of their specific components, but I would like to know more about: -the intensity of the intervention (number of individual / group sessions, length of individual / group sessions, 'homework' expected if any), therapist involvement (training of therapists, seniority of therapists), mean hours of face to face psychology /nutrition intervention (if available) Response: Extra detail has been added regarding the different programs.
-main outcome measure. The outcomes measures chosen are appropriate, and well described. However, there does not appear to be a main outcome measure that is seen by the authors as being of key importance to patients. While the study is 'exploratory / preliminary', it would have been helpful to have a pre-determined primary outcome measure. Response: The outcome measure have now been divided into primary, secondary ME/CFS specific and secondary psychological for clarity. This has led to newly devised tables which we hope will clarify the importance of the functional ability and fatigue scales and also simplify the results section. -abstract / summary / key messages / limitations accurate. These are, in general, accurate, but I do think that they need to be much more limited in their claims about the effectiveness of these treatment modalities at this early stage in the development of the evidence. I do not agree that this study, for example, justifies the 'key message' 'patient-centred approaches for the management of ME-CFS reduce symptomatology over time', in the absence of a control group; or that 'psychological interventions can help individuals to regain a sense of control over their condition', when we have no data for two thirds of the psychological intervention group, who *might* have worsened, however unlikely this might seem to those of us who are 'prejudiced' in favour of such interventions. The core message, transmitted consistently in abstract, summary and key messages, needs to be 'this study provides early evidence that treatments X, Y and Z may be effective treatments for some people with CFS-ME, but, due to the study's methodological limitations, it is important that this possible treatment effect is investigated further in high quality randomised controlled studies.' Response: The language throughout the paper has been tempered so that the message reflects the data at hand more accurately and included Dr Price"s suggestion for the core message within the "key message" section of the paper. -standard of written English acceptable for publication. In general, definitely yes. However, the manuscript needs careful proof-reading for multiple but minor errors of grammar and punctuation, e.g. bottom of page 3 -averse rather than adverse; bottom of page 3-missing comma after medical management; page 5 -'patient satisfaction of such approaches CAM has been high'; Response: The paper has been proof-read by a professional proof-reader and errors corrected. As discussed above, the significant limitations of this study (non-randomised design, high drop-out, differential drop-out between groups) need to be made more explicit in abstract, discussion, and key messages, in order for publication to be justified. My concern is that publication of the manuscript as it stands might encourage the view that 'this nutritional therapy' / 'this psychological therapy' / 'this combined therapy' is / are effective treatments for people with CFS-ME. Although this study presents preliminary evidence that this might be the case, as the authors point out in their final sentence (of a very long manuscript), random assignment is needed to provide good quality evidence. Response: As per point above, the language throughout the paper has been tempered so that the message reflects the data at hand more accurately. The authors appear to be the CEO and Lead Researcher at a private health facility dedicated to the treatment of CFS-ME. Their commitment to the effective treatment of this disorder, and to research into effective treatments, is highly laudable, but their roles in this organisation and, by implication, their potential to 'benefit' from publication of research supporting their work, needs to be explicit as a potential 'conflict of interest'. Response: Conflict of interest section has been amended as above.
Reviewer: Dr Esther Crawley Consultant Senior Lecturer School of Social and Community Medicine University of Bristol 1. The study design is not appropriate to answer the research question "evaluate the effectiveness of treatments" because there isn't a control group. Response: This has been changed to: This study therefore aims to provide preliminary evidence for the utility of three types of patient-centered approaches to the management of ME/CFS over time (baseline and follow-up) offered at a private health-care center in the UK. 2. There is insufficient detail in the methods. a)For example, it is not clear how many follow up questionnaires were sent out and when. Were they sent out at regular intervals on several occasions or just once? Response: The following detail has been added: Those that expressed an interest (N = 145) were emailed a spreadsheet that contained the questionnaires and asked to complete it at their convenience. Subsequently, participants were requested to complete the questionnaire pack on a second occasion, three months from the baseline measures. b) How many patients were approached? How many agreed to take part? Without this information, it is hard to know whether the patients recruited are representative of the population of patients attending the clinic. Response: Further detail has been added for clarification: Of the 145 individuals who expressed an interest in the study, 142 time-one questionnaires were returned, equating to a 97.9% response rate at baseline (two participants from the psychology group and one from the combined group dropped out at this stage). Therefore, excluding the four cases deleted due to insufficient data, 138 Onehundred and thirty-eight cases were used for baseline analysis; individuals completed the questionnaire battery at time-one (excluding the four deleted cases); 42 participants in the psychology group, 44 in the nutrition group and 52 in the combined group. c) There is a high drop out rate. When did the drop outs happen? Immediately or at follow up? Response: As can been seen from the additional information above, the drop-outs occurred at followup. d) Page 11, line 33. The authors excluded cases with missing data. Was this missing data at assessment? Which groups were these patients allocated to? Did they have data at outcome? The authors should consider including the data and reporting N at assessment. Response: Four cases were excluded at baseline due to incomplete data as in some cases numerous pages of the questionnaire were missing, i.e. more than 5% of data was missing hence case deletion was conducted to deal with this as advised by Tabachnick and Fidell (Using multivariate statistics. 4th ed. Needham Heights, MA: Allyn & Bacon; 2001.) The following detail has been added to clarify which groups the excluded cases were from: therefore these were excluded from the analysis (one individual from the nutrition group and three from the combined group). 3. The statistical methods are not appropriate because the authors need to correct for variations at baseline. Response: The statistical test used to investigate differences from time-one to time-two were Wilcoxon Signed Ranks test as the data was not suitable for parametric tests. We accept the point that comparisons across groups should include correction for variations at baseline (here general fatigue, physical fatigue and swollen lymph nodes and glands), which would involve either analysis of covariance (ANCOVA) or multivariate analysis of covariance (MANCOVA), both of which are not suitable for non-parametric data. However, we have now conducted these tests on the outcome variables with controls for baseline variation and the results were non-significant. Therefore, we have removed these findings from the paper and stated that with control for variation at baseline, no significant differences were observed between the three groups. 4. The authors should refer to the recently published PACE trial, a large definitive trial investigating CBT, GET and adaptive pacing. Response: This study has now been referred to in the introduction.
5. The tables are very unwieldy and need to be greatly improved. It may be easier to present the results when proper statistical analyses has been performed. Response: The tables have been shortened to take into account the division of outcomes into primary and secondary and some tables have been removed to reflect the reanalysis. 6. Throughout the results, the authors report "significant differences" (for example, Page 14, line 34). The authors need to clarify what they mean. I assume they are not talking about clinically significant change but what some authors call "statistically significant differences". The Authors may wish to read Sterne and Davey-Smith discussion on the problems or reporting statistically significant results (BMJ 2001; 322(7280):226-231.) Response: We have now noted that the significant differences are statistical, rather than clinical. 7. In the discussion, the authors need to be clearer about the limitations of this study. For example, drop out was not equal across all groups. In the psychology group the drop out was highest with retention rates varying from 33% (14/42), 61% (27/44), 40% (31/52). However this is not discussed. Response: This has now been discussed: Also, there was a high drop-out rate from time-one to timetwo and this rate differed across groups. The highest drop-out rate was in the psychology group; whilst we cannot be sure why this occurred, it is postulated that the retention was poor in the group as the individuals in the psychology program had more activities to engage in and may have felt overburdened with the research questionnaires in addition to their session and homework (this would not be the case in the combined group as the therapeutic activities are phased-in as mentioned above). 8. The authors need to take care over some of their conclusions. For example page 16, line 8: "Considering that the options available on the National Health Service, mainly CBT and GET, are often perceived as coping strategies at best, and physically damaging at worst" may be considered inflammatory by many of your readers. In addition, the statements such as " tailored treatments such as described here may be more palatable, and hence effective." (page 16) go beyond the evidence presented in this paper. Response: This statement has been removed. The authors have stated that they "have conducted tests on the outcome variables with controls for baseline variation and the results were non-significant. Therefore, we have removed these findings from the paper and stated that with control for variation at baseline, no significant differences were observed between the three groups". I cannot find a description that they have done this analyses in the paper, nor can I find the results of this analyses. Please can the authors describe where they have made the changes (page number and line).
VERSION 2 -REVIEW REVIEWER
In the results section of the paper, the authors report an improvement in "physical functioning, role limitations pain etc" (page 16, lines 11 -22). Is this based on mean differences between the groups at time 1 and time 2? Or is it based on percentage change? If it is based on percentage change (as suggested in the methods), is this mean difference between the groups as a whole? Or is this percentage change only for the smaller number of patients included in the analyses. Please can the authors clarify. RESULTS & CONCLUSIONS There are several outcome papers that are not included in the discussion.
REPORTING & ETHICS
I think it would be helpful if the authors could clarify their financial interest in the Optimum clinic not just their position within the organisation.
GENERAL COMMENTS
In the first review I suggested that the tables were unwieldy and should be shortened. Response: Firstly, may we clarify that we are looking for two types of difference: between-groups and change over time. However, as the data is not suitable for parametric test, we cannot perform mixed analysis of variance tests. We do not feel that regressions are appropriate here when looking at group differences as we are not attempting to predict outcomes; therefore our first choice for analysis of between-group differences was analysis of variance (ANOVA) for three independent groups. However, as previously mentioned, the data did not satisfy parametric assumptions so this was not possible; hence we conducted Kruskal-Wallis tests. We did take on board Dr Crawley"s previous point that correcting for baseline variation would be an appropriate way to analyse the data so we did indeed carry out ANCOVAs which illustrated non-significant results across the three groups; therefore we excluding these findings and reported this on page 20, lines 16-18, to save space (we would be happy to include these analyses as a supplemental note however). The Wilcoxon signed ranks tests refer to the within-participants comparisons, i.e. change over time, not between the three treatment groups. We included means within the tables for illustrative purposes, however we appreciate that Wilcoxon signed ranks tests do not compare means so we would kindly ask the managing editor which measure of dispersion would be more appropriate for the BMJ Open here, means or mean ranks, and we will amend accordingly. We have taken statistical advice from a number of external colleagues and believe that ours methods are correct for the data. We would have preferred to have data that could have been analysed by parametric tools as these are more powerful but we cannot ignore the assumptions of parametric testing. Non-parametric test are by their nature more conservative, therefore our findings are also conservative. The authors have stated that they "have conducted tests on the outcome variables with controls for baseline variation and the results were non-significant. Therefore, we have removed these findings from the paper and stated that with control for variation at baseline, no significant differences were observed between the three groups". I cannot find a description that they have done this analyses in the paper, nor can I find the results of this analyses. Please can the authors describe where they have made the changes (page number and line). Response: We did not include these analyses in the last version of the paper due to space (as stated above). It has been challenging to add additional text for the clarification of points without excluding some areas so we decided to remove the details of this analysis. This is noted on page 20, lines 16-18 as above.
In the results section of the paper, the authors report an improvement in "physical functioning, role limitations pain etc" (page 16, lines 11 -22). Is this based on mean differences between the groups at time 1 and time 2? Or is it based on percentage change? If it is based on percentage change (as suggested in the methods), is this mean difference between the groups as a whole? Or is this percentage change only for the smaller number of patients included in the analyses. Please can the authors clarify. Response: These analyses relate to within-participant differences, as inferred by the sub-title of the section "comparisons from time-one to time-two", i.e. we are not looking at between-group differences here. However, this sub-title has been changed to "Comparisons within-groups across time" for clarification, page 15, line 47. The tests used for these analyses are Wilcoxon signed rank tests (i.e. non-parametric version of the within-participants t-test) and the findings are reported in the tables to save space in the main body of the paper. Of the comparisons that were significant, we calculated the percentage change over time to illustrate change in scores; therefore the analysis was not carried out on change scores. The percentage change refers to the participants that completed both batteries of questionnaires (time-one and time-two) as it is not possible to estimate change on data that does not exist.
There are several outcome papers that are not included in the discussion. Response: The following statement has been added: These findings appear consistent with outcomes from other psychological interventions 3;4;6. Page 21, lines 9-11 I think it would be helpful if the authors could clarify their financial interest in the Optimum clinic not just their position within the organisation. Response: Alex Howard owns 100% shares in the clinic. Megan Arroll is not a shareholder but has an on-going contract with the clinic for research-related activities.
In the first review I suggested that the tables were unwieldy and should be shortened. Response: The findings were positioned in the tables due to the word count. We are now over the word limit due to extended clarification of points made in the first round of reviews; therefore we feel that even more text in the main body of the paper would result in an article that would not be readerfriendly. As tables are opened in new window on the BMJ Open webpage, we feel that it would be better to keep the word count as close as possible to the suggested limit and the data in the tables as readers can navigate between these. However, if the managing editor would agree on an extended word count, we would be happy to add the negative findings in the text.
Previous comments with responses and page/line numbers for reference. From the managing editor It is very important for the credibility of the article (and our journal) that any potential competing interests are declared. The Optimum Health Clinic's website states: "The Optimum Health Clinic Research Department was established in June 2011 by Alex Howard, with Dr Megan Arroll. The aim of the department is to develop a high quality evidence base for the OHC approach, and to publish the findings in high impact scientific journals. The goal is that this will be a significant step towards government funding being available for treatment at OHC." Therefore the statement that there are no competing interests is arguably not entirely accurate. Please can you make clear your relationships to the OHC in the competing interests statement? Response: Information added into the competing interests sub-heading: Alex Howard is the founder and CEO of the Optimum Health Clinic and Megan Arroll is the Director of Research at the Optimum Health Clinic, where this study was conducted. Page 24, lines 40-42 With regard to the title/abstract/methods -please try to frame the research question more clearly in the title, while including the study design. 'Longitudinal' is arguably inaccurate as this applies to studies that are carried out for much longer than three months. Response: The title has been altered to a "preliminary prospective study". Page, line: Title not on main document. Were either of the authors one of the 'practitioners who recommends the best course of action for his/her needs'? Please state in the paper. Response: The following clarification was added: (please note, this was not either of the authors of the current study). Page 7, lines 20-22
symptoms over a period of three months, and whether there are differences in treatment effectiveness between X, Y and Z'. The correct study design for this question is the RCT. The authors mention the preliminary nature of this study but, in my view, they fall into the trap of assigning causality to changes in symptoms which are unjustified with this level of evidence. There are several important limitations which very significantly limit the ability to assign causality -non-randomised design; high drop out rate (about 50%); and differential drop-out rate between groups (from 67% in the psychology group to 40% in the nutrition and combined groups).
Response However, there does not appear to be a main outcome measure that is seen by the authors as being of key importance to patients. While the study is 'exploratory / preliminary', it would have been helpful to have a pre-determined primary outcome measure. Response: The outcome measure have now been divided into primary, secondary ME/CFS specific and secondary psychological for clarity. This has led to newly devised tables which we hope will clarify the importance of the functional ability and fatigue scales and also simplify the results section. Page 10, line 20 Page 11, line 40 Page 12, line 13 -abstract / summary / key messages / limitations accurate. These are, in general, accurate, but I do think that they need to be much more limited in their claims about the effectiveness of these treatment modalities at this early stage in the development of the evidence. I do not agree that this study, for example, justifies the 'key message' 'patient-centred approaches for the management of ME-CFS reduce symptomatology over time', in the absence of a control group; or that 'psychological interventions can help individuals to regain a sense of control over their condition', when we have no data for two thirds of the psychological intervention group, who *might* have worsened, however unlikely this might seem to those of us who are 'prejudiced' in favour of such interventions. The core message, transmitted consistently in abstract, summary and key messages, needs to be 'this study provides early evidence that treatments X, Y and Z may be effective treatments for some people with CFS-ME, but, due to the study's methodological limitations, it is important that this possible treatment effect is investigated further in high quality randomised controlled studies.' Response: The language throughout the paper has been tempered so that the message reflects the data at hand more accurately and included Dr Price"s suggestion for the core message within the "key message" section of the paper. Page 1, lines 23-25 Page 2, lines 7-11 & 32-50 -standard of written English acceptable for publication. In general, definitely yes. However, the manuscript needs careful proof-reading for multiple but minor errors of grammar and punctuation, e.g. bottom of page 3 -averse rather than adverse; bottom of page 3-missing comma after medical management; page 5 -'patient satisfaction of such approaches CAM has been high'; Response: The paper has been proof-read by a professional proof-reader and errors corrected. As discussed above, the significant limitations of this study (non-randomised design, high drop-out, differential drop-out between groups) need to be made more explicit in abstract, discussion, and key messages, in order for publication to be justified. My concern is that publication of the manuscript as it stands might encourage the view that 'this nutritional therapy' / 'this psychological therapy' / 'this combined therapy' is / are effective treatments for people with CFS-ME. Although this study presents preliminary evidence that this might be the case, as the authors point out in their final sentence (of a very long manuscript), random assignment is needed to provide good quality evidence. Response: As per point above, the language throughout the paper has been tempered so that the message reflects the data at hand more accurately. The authors appear to be the CEO and Lead Researcher at a private health facility dedicated to the treatment of CFS-ME. Their commitment to the effective treatment of this disorder, and to research into effective treatments, is highly laudable, but their roles in this organisation and, by implication, their potential to 'benefit' from publication of research supporting their work, needs to be explicit as a potential 'conflict of interest'. Response: Conflict of interest section has been amended as above.
Reviewer: Dr Esther Crawley Consultant Senior Lecturer School of Social and Community Medicine University of Bristol 1. The study design is not appropriate to answer the research question "evaluate the effectiveness of treatments" because there isn't a control group.
Response: This has been changed to: This study therefore aims to provide preliminary evidence for the utility of three types of patient-centered approaches to the management of ME/CFS over time (baseline and follow-up) offered at a private health-care center in the UK. Page 6, lines 43-46 2. There is insufficient detail in the methods. a)For example, it is not clear how many follow up questionnaires were sent out and when. Were they sent out at regular intervals on several occasions or just once? Response: The following detail has been added: Those that expressed an interest (N = 145) were emailed a spreadsheet that contained the questionnaires and asked to complete it at their convenience. Subsequently, participants were requested to complete the questionnaire pack on a second occasion, three months from the baseline measures. Page 7, line 32 & 45-48 b) How many patients were approached? How many agreed to take part? Without this information, it is hard to know whether the patients recruited are representative of the population of patients attending the clinic. Response: Further detail has been added for clarification: Of the 145 individuals who expressed an interest in the study, 142 time-one questionnaires were returned, equating to a 97.9% response rate at baseline (two participants from the psychology group and one from the combined group dropped out at this stage). Therefore, excluding the four cases deleted due to insufficient data, 138 cases were used for baseline analysis; 42 participants in the psychology group, 44 in the nutrition group and 52 in the combined group. Page 14, lines 8-20 c) There is a high drop out rate. When did the drop outs happen? Immediately or at follow up? Response: As can been seen from the additional information above, the drop-outs occurred at followup. d) Page 11, line 33. The authors excluded cases with missing data. Was this missing data at assessment? Which groups were these patients allocated to? Did they have data at outcome? The authors should consider including the data and reporting N at assessment. Response: Four cases were excluded at baseline due to incomplete data as in some cases numerous pages of the questionnaire were missing, i.e. more than 5% of data was missing hence case deletion was conducted to deal with this as advised by Tabachnick and Fidell (Using multivariate statistics. 4th ed. Needham Heights, MA: Allyn & Bacon; 2001.) The following detail has been added to clarify which groups the excluded cases were from: therefore these were excluded from the analysis (one individual from the nutrition group and three from the combined group). Page 12, lines 51-53 3. The statistical methods are not appropriate because the authors need to correct for variations at baseline.
Response: The statistical test used to investigate differences from time-one to time-two were Wilcoxon Signed Ranks test as the data was not suitable for parametric tests. We accept the point that comparisons across groups should include correction for variations at baseline (here general fatigue, physical fatigue and swollen lymph nodes and glands), which would involve either analysis of consisted of very few cases in variables were it appeared, hence less than 5%) and re-analysed the data. Page 12, lines 30-34; pages 28-40 In the authors response, they have said they cannot make the tables easier to read because of the word count. I would suggest that the authors consider cutting the last three paragraphs in the introduction as they are not necessary and do not add to this report. Response: The managing editor has stated that word count is not an issue with BMJ Open; therefore we have retained the paragraphs mentioned above but simplified the tables. We sincerely hope that these are now clear and easier to read.
